Up to 2022, Novo Nordisk
expects to hire 6,000 new employees in Denmark, half of whom will work within
research and development. The new jobs will have the derived effect of boosting
employment by more than 15,000 jobs nationally.
This is revealed by a new
analysis to be presented by Novo Nordisk today at the ‘Invitation to growth – a
road to job creation’ conference. The analysis homes in on the value created in
the interaction between growth businesses and public-sector research and
education, as well as the challenges that must be solved so that research-based
businesses can continue to grow in Denmark.
"With the expectation of
creating 6,000 new jobs in Denmark over the coming years, it will be crucial
for Novo Nordisk that Denmark educates world-class graduates but also focuses
far more intently on attracting international talent," says Executive Vice
President and Chief Science Officer Mads Krogsgaard Thomsen.
The analysis presents new
forecasts for the future availability of university graduates and PhDs and
questions whether Denmark is investing sufficiently in the frameworks that are
necessary for providing strong research-based degree programmes.
The conference is being hosted
today by Novo Nordisk from 12.30 to 16.30 at the company’s headquarters in
Bagsværd. The debaters will include Danish Minister for Higher Education and
Science Sofie Carsten Nielsen; Chair of the Government’s Expert Committee on
Quality in Higher Education Jørgen Søndergaard; Rector of the University of
Copenhagen Ralf Hemmingsen; and the political spokespersons for the Liberal
Party of Denmark and the Danish Social Democrats.